Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Now Buy Phentermine Online Legally from the New Website Newtonfurn.com

 



(Medical-NewsWire.com, June 02, 2012 )

Los Angeles, Ca -- People that want to control their eating habits and lose weight are flocking to the new website Newtonfurn.com to learn about and find out how to buy phentermine online. Phentermine pills are a highly effective appetite suppressant that is producing amazing results for users throughout the country.



For many people, dieting and exercise can yield limited results in their weight loss struggle as their primary problem is portion control. A forced portion control regimen can often lead to hunger pangs as well as loss of concentration and energy. There are countless diet pills, powders, and shakes on the market that promise results, but they ultimately fall prey to these factors and disappointing results overall. Now, the new website Newtonfurn.com provides information and a way to buy cheap phentermine online. “Phentermine diet pills have become a leading appetite suppressant pill that delivers the added boost that people need to stick to their diets, and our website gives information and access to them at a reduced cost,” said a Newtonfurn.com website spokesperson.



Today’s hectic schedule for most people makes it difficult to break poor eating habits. Phentermine is an effective tool in pill form that works by reducing food cravings that can steer anyone off course. Dieters have the help they need to stop those hunger pangs and stick to their diets with the ability to buy phentermine diet pills without prescription. The pills have been proven to help dieters feel more satisfied between meals, which makes it less likely that they will stray from their diet by eating unhealthy snacks.



Results can be seen after only a few weeks of use. In fact, many notice a decrease in appetite on the very first day of taking phentermine. Dieters are freed from the need to spend a fortune on ineffective pills and can buy phentermine without prescription directly from the new website Newtonfurn.com. Order today and they will rush deliver a pack of phentermine diet pills at an amazing price. “Losing weight is all about empowerment—making smart choices that will benefit you throughout your life,” said the website spokesperson. “Phentermine diet pills have been proven to help people focus on their weight loss goals without worrying about getting off track through unhealthy food temptations.” For more information, please visit http://www.newtonfurn.com/



About Newtonfurn.com:



The new website provides not only information, but also access to the effective phentermine diet pills. Phentermine is an effective tool in pill form that works by reducing food cravings that can make it difficult to adhere to diets. The website provides access to phentermine pill packs that can be purchased at a highly reduced price without a prescription.



###

Newtonfurn.com

Jack Almeida

(949) 436 1290

contact@1111media.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Biden gets papal blessing for his global war on cancer
29 Apr 2016 at 5:52am

U.S. Vice President Joe Biden took his crusade against cancer to the Vatican on Friday and heard Pope Francis call for an "economic paradigm shift" where medical research is dictated by need rather than profit. Biden, who lost his 46-year-old son Beau to brain cancer last year, has vowed to pursue a global push to accelerate cancer cures and treatments by marshalling private and public sector resources to combat it as well as rare diseases. Biden, who flew to Italy from an unannounced trip to Iraq, and the pope, made back-to-back speeches to doctors and researchers from around the world who attended a Vatican conference on regenerative medicine called "Cellular Horizons".



Shire jumps as Vyvanse drug helps it to beat earnings forecast
29 Apr 2016 at 5:52am

By Ben Hirschler LONDON (Reuters) - Strong demand for Shire's top-selling Vyvanse drug helped to lift first-quarter earnings by a better than expected 12 percent, boosting the London-listed group's shares ahead of its $32 billion acquisition of U.S. rare diseases specialist Baxalta . Sales of Vyvanse, a treatment for attention deficit hyperactivity disorder (ADHD), rose 22 percent, partly reflecting the drug's recent approval as a treatment for binge eating disorder (BED). "Shire is off to a strong start in 2016," said Chief Executive Flemming Ornskov, who has faced investor criticisms over his pay.


Bohra Muslim leader speech urging FGM is 'huge disappointment' for India camp...
29 Apr 2016 at 5:42am
By Rina Chandran MUMBAI (Thomson Reuters Foundation) - A speech by the spiritual leader of the Dawoodi Bohra community, in which he appears to be urging followers in India to continue the practice of female genital mutilation (FGM), has angered and upset campaigners trying to end the centuries-old practice. The audio clip of Syedna Muffadal Saifuddin's speech at a mosque in Mumbai, has been authenticated by several members of the community. A person described as a close friend of the Syedna family told the Times of India newspaper that the remarks were a "general comment" and that people were "interpreting it differently".


Valeant files annual report, says in compliance with covenants
29 Apr 2016 at 5:28am

(Reuters) - Beleaguered Canadian drugmaker Valeant Pharmaceuticals International Inc filed its long-delayed annual report on Friday, in which it identified misstatements that would reduce some of its previously reported revenue. Valeant said it was in compliance with its credit agreement and senior note indentures and that no additional restatements were required beyond those previously disclosed.



Japan's corpse hotels upset some of the neighbors
29 Apr 2016 at 4:48am

Tucked away in a quiet residential street in Kawasaki city in Japan is a refurbished workshop with a plain silver exterior and black draped windows that residents describe as creepy. The business inside, Sousou, is one of Japan's latest so-called corpse hotels, a camouflaged morgue used to store some of Japan's mounting pile of bodies waiting for a spot in one of the nation's overworked crematoriums. ?Crematories need to be built, but there isn?t any space to do so and that is creating funeral refugees," said Hisao Takegishi, who opened the business in 2014.



Biogen, AbbVie multiple sclerosis drug wins EU green light
29 Apr 2016 at 4:29am

A once-monthly injection for multiple sclerosis from Biogen and AbbVie has been recommended for approval by European regulators, paving the way for its launch in the coming months. The European Medicines Agency said on Friday its experts had endorsed Zinbryta, or daclizumab, for the treatment of relapsing forms of multiple sclerosis (MS), adding a new option to a range of modern MS therapies. The positive opinion will now be referred to the European Commission, which normally grants marketing authorizations for medicines recommended by the agency within a couple of months.



Iran moderates eye more gains in run-off parliamentary election
29 Apr 2016 at 4:13am

By Parisa Hafezi ANKARA (Reuters) - Iranians lined up outside polling stations on Friday to vote in a second round of parliamentary elections, with allies of reformist President Hassan Rouhani seeking to wrest more seats from hardliners. Rouhani's moderate and centrist allies made big gains in elections on Feb. 26 for parliament and a clerical body that will elect the next Supreme Leader, but they failed to win a majority of the 290-member assembly. Interior Minister Abdolreza Rahmani Fazli, speaking on Iranian state television, said people would vote on 68 undecided seats in constituencies where candidates failed to get 25 percent of votes cast in the first round.



Sanofi confident it can win Medivation shareholders support
29 Apr 2016 at 4:02am

Sanofi , which reported higher quarterly profit on Friday boosted by its Genzyme division, is confident Medivation shareholders will back its proposed takeover of the U.S. cancer drug company. The French drugmaker went public on Thursday with a $9.3 billion offer to buy Medivation after it stonewalled its takeover approach, setting up what could be a lengthy battle. "We are confident that Medivation shareholders will ultimately share our strong belief that our offer ... would provide significant and immediate cash value," Sanofi Chief Executive Olivier Brandicourt said on a conference call.



Diabetes drug test results boost Novo Nordisk
29 Apr 2016 at 3:25am

(This April 28 story corrects the fifth paragraph to say that two, not one, other diabetes drugs have positive cardiovascular side-effects) COPENHAGEN (Reuters) - Novo Nordisk said on Thursday a late-stage trial showed its new once-weekly diabetes drug significantly reduced patients' cardiovascular risks, boosting the company's hopes of maintaining its lead in the fast-growing diabetes market. The trial, dubbed SUSTAIN 6, showed the drug - called semaglutide - delivered a "statistically significant reduction in cardiovascular risk" compared with placebo in patients with type 2 diabetes. Cardiovascular risks are often higher among diabetes patients because they tend to be overweight.



AstraZeneca cuts costs and doubles down on cancer drugs
29 Apr 2016 at 3:15am

By Ben Hirschler LONDON (Reuters) - AstraZeneca is to cut costs by $1 billion and increase its focus on cancer treatments after underlying earnings, hit by drug patent expiries, fell 12 percent in the first quarter, broadly in line with analyst expectations. Chief Executive Pascal Soriot said on Friday he would sharpen the prioritization of investments and increase spending in oncology while cutting commercial and manufacturing operations. There will be job losses, reflecting the fact that specialist cancer drugs require smaller sales forces than ones sold to general practitioners.


Reformulated GSK mouthwash endorsed as umbilical cord antiseptic
29 Apr 2016 at 2:01am
By Ben Hirschler LONDON (Reuters) - An antiseptic gel to stop umbilical cord infections in newborn babies was recommended as safe and effective by European regulators on Friday in a boost for GlaxoSmithKline scientists who developed it from a mouthwash. GSK researchers developed the new product by reformulating the chlorhexidine solution found in its popular Corsodyl mouthwash into a gel that can be applied to newly cut umbilical cords. The stump of the umbilical cord can act as an entry point for bacteria, causing life-threatening infections, especially in poorer countries with limited healthcare resources.


Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
29 Apr 2016 at 1:52am

By Ben Hirschler and Leigh Thomas LONDON/PARIS (Reuters) - French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover battle after the U.S. cancer firm rebuffed its approaches. The decision to target Medivation marks a return to the biotech takeover trail for Sanofi, which is looking to new cancer treatments to bolster its portfolio and help offset declining sales of mainstay diabetes drug Lantus. Sanofi's non-binding proposal is to buy Medivation for $52.50 per share in cash, representing a roughly 36 percent premium over Medivation's stock price one month prior to Thursday's offer.



Hackett says drink not drugs behind mile high meltdown
29 Apr 2016 at 12:33am

Australian long distance swimming great Grant Hackett has admitted that binge drinking was behind his altercation with another passenger on a flight earlier this month and said he was seeking help to quit alcohol. The 35-year-old former Olympic champion was spoken to by police after the incident on a flight from the Australian Olympic trials in Adelaide to Melbourne. Hackett has admitted to a dependence on prescription drugs in the past but said on Friday that the incident on the plane had come after he had been drinking in the wake of his failure to secure a spot on the team for this year's Rio Olympics.


Swimming-Hackett says drink not drugs behind mile high meltdown
29 Apr 2016 at 12:22am
Australian long distance swimming great Grant Hackett has admitted that binge drinking was behind his altercation with another passenger on a flight earlier this month and said he was seeking help to quit alcohol. The 35-year-old former Olympic champion was spoken to by police after the incident on a flight from the Australian Olympic trials in Adelaide to Melbourne. Hackett has admitted to a dependence on prescription drugs in the past but said on Friday that the incident on the plane had come after he had been drinking in the wake of his failure to secure a spot on the team for this year's Rio Olympics.


Liberian soccer star-turned-politician Weah to run for president
29 Apr 2016 at 12:03am

By James Harding Giahyue CONGO TOWN, Liberia (Reuters) - Liberian international soccer star-turned-politician George Weah said on Thursday he will make a second bid for the presidency of the impoverished West African nation in an election next year. Chanting "You can have the whole world but give me Weah," thousands of his backers packed onto the grounds of his Congress for Democratic Change (CDC) headquarters in the capital, Congo Town, to listen to the announcement. Liberia has spent more than a decade rebuilding from a long civil war that ended in 2003 and decimated infrastructure in the nation founded in the 19th century by freed American slaves.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC